ALKS vs WTW · P/E 14, rev $1.56B vs P/E 15, rev $9.93B
Alkermes Plc (ALKS) versus Willis Towers Watson PLC (WTW) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Willis Towers Watson PLC (WTW) is a insurance brokers company listed on NASDAQ.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported WTW revenue for 2024-12-31 was $9.93B. Net income was -$88.0M. Revenue was up 4.7% from 2023-12-31 to 2024-12-31. WTW currently screens at market cap $24.41B and trailing P/E 15.2.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. WTW currently screens at market cap $24.41B and trailing P/E 15.2.
Not investment advice. Open the ALKS and WTW stock pages for the full models.
Not investment advice.